Therapeutic Fraud Prevention Act

The Therapeutic Fraud Prevention Act is a bill in the United States House of Representatives that if passed would prohibit, as an unfair and deceptive act or practice, commercial sexual orientation and gender identity conversion therapy, and for other purposes.

Therapeutic Fraud Prevention Act
Full titleTo prohibit, as an unfair and deceptive act or practice, commercial sexual orientation conversion therapy, and for other purposes.
Introduced in114th United States Congress
Introduced onMay 19, 2015
Sponsored byRep. Ted Lieu
Legislative history

Introduced bills

114th Congress

On May 19, 2015, Rep. Ted Lieu (D-CA), who had authored the first such ban in California while State Senator in 2012, introduced the Therapeutic Fraud Prevention Act (H.R. 2450) in the U.S. House of Representatives.[1] The bill had 96 cosponsors.

On April 28, 2016, Sen. Patty Murray (D-WA) introduced a companion bill (S. 2880) in the U.S. Senate, where it had 21 cosponsors.[2]

115th Congress

On April 25, 2017, Rep. Ted Lieu re-introduced the Therapeutic Fraud Prevention Act (H.R. 2119) in the House of Representatives, and Sen. Patty Murray reintroduced it (S. 928) in the Senate.[3] The House bill had 110 cosponsors and the Senate counterpart had 25 cosponsors.

116th Congress

On March 28, 2019, Rep. Sean Patrick Maloney (D-NY) introduced the Prohibition of Medicaid Funding for Conversion Therapy Act (H.R. 1981) in the House of Representatives with 83 cosponsors.[4]

Support

The Human Rights Campaign has endorsed the Therapeutic Fraud Prevention Act.[5]

See also

References
  1. H.R.2450 - Therapeutic Fraud Prevention Act
  2. S.2880 - Therapeutic Fraud Prevention Act of 2016
  3. "Congressional Democrats introduce measure to ban conversion therapy". MetroWeekly. April 25, 2017.
  4. H.R.1981 - Prohibition of Medicaid Funding for Conversion Therapy Act
  5. "Therapeutic Fraud Prevention Act | Resources | Human Rights Campaign". Hrc.org. Retrieved 2015-10-31.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.